Artificial intelligence is expected to make a significant difference in the development of future drug candidates. 

The power of computers and their ability to identify patterns that humans cannot see is a major asset for pharmaceutical researchers. And we know it works—artificial intelligence had its breakthrough with the mRNA vaccine developed to combat COVID-19, and today, several drug candidates are entirely developed with the help of AI and are undergoing clinical trials.

In June 2023, Leif Eriksson, professor of chemistry at the University of Gothenburg, was invited to Nyhetsmorgon on TV4 to talk more about these possibilities.

Cures for multiple types of cancer.

He and his research team have used supercomputers to find a molecular composition that could be effective against glioblastoma, a task that would have gone much faster if they had already had access to today's AI-based tools. This is just the beginning, according to the professor.

"AI has the ability to process and handle very large data sets and do it very quickly."

Leif Eriksson believes that the group's research will lead to a cure for glioblastoma. Other types of cancer may also become relevant.

Watch the segment from TV4 Morning News here